Section Review: Central & Peripheral Nervous Systems: Novel approaches for analgesic drug assessment: new animal paradigms

References

• EDDY NB, LEIMBACH D: Synthetic analgesics. II. Dithienyl-butenyl- and dithknylbutylataines. J. Phar-macol. Exp. Ther. (1953) 107:385–393.
   PubMed Web of Science ®Google Scholar
• WOOLFE G, MACDONALD AD: The evaluation of analge-sic action of pethidine hydrochloride (demerol). Pharmacol. Exp. Ther. (1944) 80:300–307.
   Google Scholar
• D'AMOUR FE, SMITH DL: A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. (1941) 72:4–79.
   Google Scholar
• ABBOTT FV, MELZACK R: Morphine analgesia in the tail-flick and formalin pain tests is mediated by differ-ent neural systems. Exp. Neurol. (1982) 75:644–651.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER C: Effects of morphine-like drugs in chicks. Nature. (1961) 191:607–608.
   PubMed Web of Science ®Google Scholar
• RANDALL LO, sEurro jj: A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharma-codyn. Ther. (1957) 111:409–419.
   PubMedGoogle Scholar
• DUBUISSON D, DENNIS SG: The formalin test: A quanti-tative study of the analgesic effects of morphine, meperidine, and brainstem stimulation in rats and cats. Pain (1977) 4:161–164.
   PubMed Web of Science ®Google Scholar
• KOSTER R, ANDERSON M, DE BEER EJ: Acetic acid for analgesic screening. Fed. Proc. (1959) 18:412.
   Google Scholar
• JAFFE JH, MARTIN WR: Opioid analgesics and antago-nists. In: Goodman and Gilman 's The Pharmacological Basis of Therapeutics (8th Edition). Gilman AG, Rail TV17, Nies AS, Taylor P (Eds.), Pergamon Press, New York (1990).
   Google Scholar
• MARTIN WR: Pharmacology of opioids. Pharmacol. Rev. (1983) 35:83–323.
   Google Scholar
• PIRCIO AW, FEDELE CT, BIERGWAGEN ME: Anew method for evaluation of analgesic activity using adjuvant-in-duced arthritis in the rat. Eur.J. Pharrnacol. (1975) 31:207–215.
   PubMed Web of Science ®Google Scholar
• WHEELER-ACETO H, COWAN A: Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharrnacology (1991).104:35–44.
   PubMed Web of Science ®Google Scholar
• LOPEZ-MUNOZ FJ, SALAZAR LA, CASTANEDA-HERNADEZ G, VILLARREAL JE: A new model to assess analgesic activity: pain-induced functional impairment in the rat (PIFIR). Drug Dev. Res. (1993) 28:169–175.
   Web of Science ®Google Scholar
• BENNETT G, XIE Y-K: A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 33:87–107.
   PubMed Web of Science ®Google Scholar
• SELTZER Z, DUBNER R, SHIR Y: A novel lbehavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain (1990) 43:205–218.
   PubMed Web of Science ®Google Scholar
• DE CASTRO COSTA MC, DE SUTTER P. GYBELS J, VAN HAES J: Adjuvant-induced arthritis in rats: a possible model for chronic pain. Pain (1981) 10:173–185.
   PubMed Web of Science ®Google Scholar
• COLPAERT FC: Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain (1987) 28:201–222.
   PubMed Web of Science ®Google Scholar
• STEIN C, MILLAN MJ, HERZ A: Unilateral inflammation of the hind-paw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds. Pharmacol. Biochem. Behav. (1988) 31:445–451.
   PubMed Web of Science ®Google Scholar
• WINTERS CA, RISLEY EA, NUSS GW: Carrageenaan-in-duced edema in hind paw of the rat as an assay for antiinflanunatory drugs. Proc. Soc. Exp. Biol. Med. (1962) 111:544–547.
   PubMedGoogle Scholar
• STANFA LC, SULLIVAN AF, DICKENSON AH: Alterations inneuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenan-induced Inflammation. Pain (1992) 50:345–354.
   PubMed Web of Science ®Google Scholar
• CODERRE TJ, WALL PD: Ankle joint urate arthritis (AJUA) In rats: an alternative animal model of arthritis to that produced by Freund's adjuvant. Pain (1987) 28:379–393.
   PubMed Web of Science ®Google Scholar
• CODERRE TJ, WALL PD: Ankle joint urate arthritis in rats provide a useful tool for the evaluation of analgesic and anti-arthritic agents. Pharmacol. Biochem. Behav. (1988) 29:461–466.
   PubMed Web of Science ®Google Scholar
• LARSON J-J, ARNT J: Reduction in locomotor activity ofarthritic rats as parameter for chronic pain: effect of morphine, acetylsalicylic acid and citalopram. Acta Pbarmacol. et Toxicol. (1985) 57:345–351.
   PubMedGoogle Scholar
• JORIS J, COSTELLO A, DUBNER R, HARGREAVES KM: Opiates suppress carrageenan-induced edema and hy-perthertnia at doses that inhibit hyperalgesia. Pain (1990) 43:95–103.
   PubMed Web of Science ®Google Scholar
• REN K, HYLDEN JLK, WILLIAMS GM, RUDA MA, DUBNERR: The effects of a non-competitive NMDA receptor antagonist, MK-801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral Inflammation. Pain (1992) 50:331–344.
   PubMed Web of Science ®Google Scholar
• REN K, WILLIAMS GM, HYLDEN JLK, RUDA MA, DUBNER R: The intrathecal administration of excitatory amino add receptor antagonists selectively attenuates car-rageenan-induced behavioral hyperalgesia in rats. Eur. J. Pharmacol. (1992) 219:235–243,
   PubMed Web of Science ®Google Scholar
• MILLAN MJ, COLPAERT FC: The influence of sustained opioid receptor blockade in a model of long-term, localized inflammatory pain in rats. Neurosci. Lett. (1990) 113:50–55.
   PubMed Web of Science ®Google Scholar
• BUTLER SH, GODEFROY F, BESSONJ-M, WEIL-FUGAZZA J:A limited arthritic model for chronic pain studies in the rat. Pain (1992) 48:73–81.
   PubMed Web of Science ®Google Scholar
• KAYSER V, FOURNIE-ZALUSKI MC, GLTILBAUD G, ROQUES BP: Potent antinockeptive effects of kelatorphan (a highly efficient inhibitor of multiple enkephalin-de-grading enzymes) systemically administered in normal and arthritic rats. Brain Res. (1989) 497:94–101.
   PubMed Web of Science ®Google Scholar
• KAYSER V, GUILBAUD G: Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain (1990) 41:353–363.
   PubMed Web of Science ®Google Scholar
• PARSONS CG, CZLONKOWSKI A, HERZ A: Peripheral opioid receptors mediating antinociception in inflam-mation. Activation by endogenous opioids and role of the pituitary-adrenal axis. Pain (1990) 41:81–93.
   Google Scholar
• SUFKA KJ: Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain (1994) 58:355–366.
   PubMed Web of Science ®Google Scholar
• SUFKA KJ, ROACH IT: Stimulus properties and amino-ciceptive effects of bradykinin Bj and B2 receptor an-tagonists in rats. Pain (1996). In press.
   Google Scholar
• SUFKA KJ, FOWLER SC, LIOUJ-R, BROCICEL BJ: Functional deficits following bilateral forelimb adjuvant inflamma-tion assessed via operant methodology: effects of in-domethacin and morphine on recovery of functioning. Exp. Clin. Psychopharmacol. (1996). In press.
   Google Scholar
• SUFKA KJ, WEED NC: Construct validation of the behav-ioral indices of isolation stress and inflammatory no-ciception in young domestic fowl. Physiol. Behav. (1994) 55:741–746.
   PubMed Web of Science ®Google Scholar
• WATSON GS, MARK MJ, CARLSON ES, SUFKA KJ: The effects of chlordiaz,epoxkle on social separation stress In young domestic fowl: a novel model for screening anxiolytic drug efficacy. 25th Society for Neuroscience Meeting. San Diego, USA (1995):1685.
   Google Scholar
• CARR GD, FIBIGER HC, PHILLIPS AG: Conditioned place preference as a measure of drug reward. In: The Neuro-pharmacological Basis of Reward. Liebman JM, Cooper SJ (Eds.), Clarendon Press, Oxford (1989).
   Google Scholar
• VAN DER KOOY D: Place conditioning: a simple and effective method for assessing the motivational prop-erties of drugs. In: Methods for Assessing the Reinforcing Properties of Abused Drugs. Bozarth MA (Ed.), Springer, New York (1987).
   Google Scholar
• MUCHA RF, VAN DER KOOY D, O'SHAUGHNESSY M, BUCENIEICS P: Drug reinforcement studied by use of place conditioning in rat. Brain Res. (1982) 243:91–105.
   PubMed Web of Science ®Google Scholar
• KIMBLE GA: A modest proposal for a minor revolutionIn the language of psychology. Psych. Sci. (1993) 4:253–255.
   Google Scholar
• LEWIS AJ, CARLSON RP, CHANG J: Experimental models of inflammation_ In: The Pharmacology of Inflammation: Handbook of inflammation (Volume 5). Bonta IL, Bray MA, Pamham MJ (Eds.), Elsevier, New York (1985).
   Google Scholar
• CROWDER WF, HuTro cw: Operant place conditioning measures examined using two nondrug reinforcers. Pharmacol. Biochem. Behav. (1992) 41:817–824.
   PubMed Web of Science ®Google Scholar
• CROWDER WE, HUTTO CW: Operant place conditioning measures examined using morphine reinforcement. Pharmacol. Biochem. Behav. (1992) 41:825–835.
   PubMed Web of Science ®Google Scholar
• PERKINS MN, CAMPBELL E, DRAY A: Antinociceptive activity of the bradykinin Bi and 112 receptor antago-nists, des arg9, [Leull-BK and HOE-140, in two models of persistent hyperalgesia in the rat. Pain (1993) 53:191–197.
   PubMed Web of Science ®Google Scholar
• FIELDS HL: Relief of unnecessary suffering. In: Pharma-cological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Progress in Pain Research and Management (Volume 1). Fields HL, Liebeskind JC (Eds.), IASP Press, Seattle (1994).
   Google Scholar
• DICKENSON All: NMDA receptor antagonists as analge-sics. In: Pharmacological Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Progress in Pain Research and Management (Volume 1). Fields HL, Liebeskind JC (Eds.), IASP Press, Seattle (1994).
   Google Scholar
• PHILIPS C, HUNTER M: Pain behaviour in headache sufferers. Behar) Anal. Mod. (1981) 4:257–266.
   Web of Science ®Google Scholar
• LARSON J-J, ARNT J: Reduction in locomotor activity ofarthritic rats as parameter for chronic pain: effect of morphine, acetylsalicylic acid and citalopram. Acta Pharmacol. et Toxicol. (1985) 57:345–351.
   PubMedGoogle Scholar
• CARLTON PL: A Primer of Behavioral Pharmacology. Free-man, New York (1983).
   Google Scholar
• FOWLER SC: Force and duration of operant response as dependent variables in behavioral pharmacology. In: Neurobehavioral Pharmacology, Advances in Behavioral Pharmacology (Volume 6). Thompson T, Dews PB, Barrett JE (Eds.), Erlbaum, Hillsdale (1987).
   Google Scholar
• FOWLER SC, SKJOLDAGER PD, LIAO R-M, CHASEJM, JOHNSON JS: Distinguishing between hakoperidol's and decamethonium's disruptive effects on operant behav-ior in rats: use of measurements that complement response rate. J. Ex 1). Anal. Behav. (1991) 56:239–260.
   Google Scholar
• KALLMAN MJ, FOWLER SC: Assessment of chemically induced alterations in motor function. In: Handbook of Neurotoxicology: I. Basic Principles and Current Concepts. Chang LLW (Ed.), Marcel Dekker, Monticello (1994).
   Google Scholar
• HOLLAND LN, GOLDSTEIN BD: Changes of substance P-like immunoreactivity in the dorsal horn are associ-ated with phasic behavioral response to a formalin stimulus. Brain Res. (1990) 537:287–292.
   PubMed Web of Science ®Google Scholar
• HOLLAND LN, GOLDSTEIN BD: Examination of tonicnociceptive behavior using a method of substance P-re-ceptor desensitization in the dorsal horn. Pain (1994) 56:339–346.
   PubMed Web of Science ®Google Scholar
• KEHL LJ, TREMPE TM, HARGREAVES KM: Intramuscularadministration of carrageenan reduces grip force strength in rats. 25th Society for Neuroscience Meeting. San Diego, USA (1995):898.
   Google Scholar